1/2

Trusted Supplier

FIEO Registered Export Ready

VQ-SAP X

Name: VQ-SAP X
SKU: 8618782
Availability: InStoreOnly

Sold by Swasti Exports · Manufacturer, Trader, Exporter, Importer · Vadodara, Gujarat, India

Price

Price on request

In stock

Minimum order: 1 unit

Export Snapshot

MOQ

1 unit

Lead time

On request

Packaging

Standard export packaging

Shelf life / longevity

As per product specification

HS Code

On request

Origin

India

Port of dispatch

On request

Export markets served

United States Minor Outlying Islands flag

Values shown are for Swasti Exports.

Compliance & Certifications

IEC Certificate

Suitable for

Importers · Distributors · Wholesalers

Vadodara Dispatch on request FIEO member

Swasti Exports

Manufacturer, Trader, Exporter, Importer · Vadodara, Gujarat, India

We are Merchant Exporter and supplying Chemicals, Agriculture products, Rices, spices, Kashmiri Saffron, Iranian saffron, Dates and so many products.

Registered address: Vadodara, India. Industry: Chemicals, Dyes & Paints > Chemical Industry Related Services.

View profile All products

Established

2020

Employees

1–10

GST

24AIXPB0733C1ZO

IEC code

AIXPB0733C

Export markets

GlobalLinker Member Since

Jul 2020

Turnover

100000 - 2500000.

Incorporation Type

On request

IEC Certificate FIEO

Product details

What are the specifications of this product?

Overview

A premium triterpenoid saponin fraction, meticulously extracted from the strictly selected inner bark of the Soapbark tree (Quillaja saponaria Molina).

Product Description

Engineered with proprietary chromatographic separation technology, this adjuvant precisely isolates synergistic bio-active fractions to maximize immune response while significantly reducing reactogenicity (side effects).Designed to deliver superior immunogenicity for recombinant protein, subunit, and mRNA vaccines. Highly recommended for premium veterinary vaccine formulations.

Description provided by Swasti Exports.

Specifications

Product Name	VQ-SAP X
Brand/Store Name	Swasti Exports
MOQ	1
Product Form	Saponin fraction
Source Material	Inner bark of Quillaja saponaria Molina
Extraction Method	Proprietary chromatographic separation
Application	Vaccine adjuvant
Compatibility	Recombinant protein, subunit, and mRNA vaccines
Primary Use Case	Premium veterinary vaccine formulations
Performance Focus	High immunogenicity with reduced reactogenicity

Use cases

Category	Veterinary Vaccine Adjuvants
Primary application	Wholesale, distribution, and international sourcing
Brand	Not specified
Product type	Product

Logistics & handling

Lead time	On request
Packaging	As per buyer requirement
Storage condition	As recommended by supplier
Origin	India
Form	As listed by supplier

Commercials (this seller)

Minimum order	1 unit
Lead time	On request
Payment terms	As per negotiated commercial agreement.
Checkout type	enquiry

Buyer questions

Frequently asked by buyers

Common questions B2B buyers ask before sourcing VQ-SAP X. Answers compiled from verified sellers' commercial terms and platform data.

Q: What makes VQ-SAP X different from standard saponin adjuvants?

A: VQ-SAP X is refined using proprietary chromatographic separation technology to isolate synergistic bioactive fractions, which is intended to improve immunogenic response while reducing reactogenicity compared with less purified saponin materials.

Q: Which vaccine platforms is VQ-SAP X most suitable for?

A: It is designed for recombinant protein vaccines, subunit vaccines, and mRNA vaccine formulations, where a strong adjuvant effect and controlled side-effect profile are important.

Q: Why is the inner bark source important for this product?

A: The product is derived from strictly selected inner bark of Quillaja saponaria Molina, which supports consistent raw material selection and is important for producing a premium, reproducible saponin fraction.

Q: Is VQ-SAP X specifically recommended for veterinary applications?

A: Yes. The product description highlights it as highly recommended for premium veterinary vaccine formulations, making it especially relevant for animal health vaccine development.

Q: What performance goal does the product address in vaccine formulation?

A: It is engineered to maximize immune response and immunogenicity while significantly reducing reactogenicity, helping formulators balance potency with tolerability.

Question not answered? Ask sellers directly — typical response within 4 hours.